Home › Funds › Corundum Group, Inc. › JNJ

Corundum Group, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Corundum Group, Inc. reported holding 7,996 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 0.73% of its reported portfolio and ranking #28 among its reported holdings. Corundum Group, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.00K sh
Reported value held$2.12M
Portfolio Weight0.73%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Corundum Group, Inc.'s JNJ position evolved

Corundum Group, Inc. first disclosed a stake in JNJ in Q3 2023 at 10,608 shares (US$1.7M). The position peaked in Q3 2026 at 7,996 shares, worth US$2.1M. Across 13 filings, Corundum Group, Inc. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 7,996 shares valued at US$2.1M — an increase of 241 shares quarter over quarter.. Notable position changes include a 42% trim in Q4 2023 (shares rose 1% over the following quarter), a 38% increase in Q1 2024 (shares fell 8% over the following quarter), a 29% increase in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.61K $1.65M New
Q4 2023 6.20K $972.26K Reduce
Q1 2024 8.59K $1.36M Add
Q2 2024 11.07K $1.62M Add
Q3 2024 8.16K $1.32M Reduce
Q4 2024 8.21K $1.19M Add
Q1 2025 7.55K $1.25M Reduce
Q2 2025 7.43K $1.13M Reduce
Q3 2025 7.36K $1.37M Reduce
Q4 2025 7.33K $1.52M Hold
Q1 2026 7.78K $1.90M Add
Q2 2026 7.75K $1.97M Hold
Q3 2026 8.00K $2.12M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Corundum Group, Inc. held JNJ?

Corundum Group, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Corundum Group, Inc.'s current position in JNJ?

As of Q3 2026, Corundum Group, Inc. holds 8.00K shares of JNJ (JOHNSON & JOHNSON), valued at $2.12M, representing 0.73% of its reported portfolio and ranking #28.

Has Corundum Group, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Corundum Group, Inc. increased its position in JNJ. The position peaked in Q3 2026 at 8.00K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.